Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Javitch, JA; Shi, L; Liapakis, G
   Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors
   G PROTEIN PATHWAYS, PT A, RECEPTORS
   
   J.A. Javitch et al., "Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors", METH ENZYM, 343, 2002, pp. 137-156
2. Visiers, I; Ballesteros, JA; Weinstein, H
   Three-dimensional representations of G protein-coupled receptor structuresand mechanisms
   G PROTEIN PATHWAYS, PT A, RECEPTORS
   
   I. Visiers et al., "Three-dimensional representations of G protein-coupled receptor structuresand mechanisms", METH ENZYM, 343, 2002, pp. 329-371
3. Lynch, JW; Han, NLR; Haddrill, J; Pierce, KD; Schofield, PR
   The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state
   JOURNAL OF NEUROSCIENCE
   
   J.W. Lynch et al., "The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state", J NEUROSC, 21(8), 2001, pp. 2589-2599
4. Teissere, JA; Czajkowski, C
   A beta-strand in the gamma(2) subunit lines the benzodiazepine binding site of the GABA(A) receptor: Structural rearrangements detected during channel gating
   JOURNAL OF NEUROSCIENCE
   
   J.A. Teissere e C. Czajkowski, "A beta-strand in the gamma(2) subunit lines the benzodiazepine binding site of the GABA(A) receptor: Structural rearrangements detected during channel gating", J NEUROSC, 21(14), 2001, pp. 4977-4986
5. Williams, DB; Akabas, MH
   Evidence for distinct conformations of the two alpha(1) subunits in diazepam-bound GABA(A) receptors
   NEUROPHARMACOLOGY
   
   D.B. Williams e M.H. Akabas, "Evidence for distinct conformations of the two alpha(1) subunits in diazepam-bound GABA(A) receptors", NEUROPHARM, 41(5), 2001, pp. 539-545
6. Ballesteros, JA; Shi, L; Javitch, JA
   Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors
   MOLECULAR PHARMACOLOGY
   
   J.A. Ballesteros et al., "Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors", MOLEC PHARM, 60(1), 2001, pp. 1-19
7. Whitehead, RE; Ferrer, JV; Javitch, JA; Justice, JB
   Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
   JOURNAL OF NEUROCHEMISTRY
   
   R.E. Whitehead et al., "Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter", J NEUROCHEM, 76(4), 2001, pp. 1242-1251
8. Da Settimo, F; Primofiore, G; Taliani, S; Marini, AM; La Motta, C; Novellino, E; Greco, G; Lavecchia, A; Trincavelli, L; Martini, C
   3-aryl[1,2,4]triazino[4,3-alpha]benzimidazol-4(10H)-ones: A new class of selective A(1) adenosine receptor antagonists
   JOURNAL OF MEDICINAL CHEMISTRY
   
   F. Da Settimo et al., "3-aryl[1,2,4]triazino[4,3-alpha]benzimidazol-4(10H)-ones: A new class of selective A(1) adenosine receptor antagonists", J MED CHEM, 44(3), 2001, pp. 316-327
9. Blaney, FE; Raveglia, LF; Artico, M; Cavagnera, S; Dartois, C; Farina, C; Grugni, M; Gagliardi, S; Luttmann, MA; Martinelli, M; Nadler, GMMG; Parini, C; Petrillo, P; Sarau, HM; Scheideler, MA; Hay, DWP; Giardina, GAM
   Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists
   JOURNAL OF MEDICINAL CHEMISTRY
   
   F.E. Blaney et al., "Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists", J MED CHEM, 44(11), 2001, pp. 1675-1689
10. Smith, SS; Liu, XH; Zhang, ZR; Sun, F; Kriewall, TE; McCarty, NA; Dawson, DC
    CFTR: Covalent and noncovalent modification suggests a role for fixed charges in anion conduction
    JOURNAL OF GENERAL PHYSIOLOGY
    
    S.S. Smith et al., "CFTR: Covalent and noncovalent modification suggests a role for fixed charges in anion conduction", J GEN PHYSL, 118(4), 2001, pp. 407-431
11. Reeves, DC; Goren, EN; Akabas, MH; Lummis, SCR
    Structural and electrostatic properties of the 5-HT3 receptor pore revealed by substituted cysteine accessibility mutagenesis
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    D.C. Reeves et al., "Structural and electrostatic properties of the 5-HT3 receptor pore revealed by substituted cysteine accessibility mutagenesis", J BIOL CHEM, 276(45), 2001, pp. 42035-42042
12. Fu, J; Kirk, KL
    Cysteine substitutions reveal dual functions of the amino-terminal tail incystic fibrosis transmembrane conductance regulator channel gating
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    J. Fu e K.L. Kirk, "Cysteine substitutions reveal dual functions of the amino-terminal tail incystic fibrosis transmembrane conductance regulator channel gating", J BIOL CHEM, 276(38), 2001, pp. 35660-35668
13. Frang, H; Cockcroft, V; Karskela, T; Scheinin, M; Marjamaki, A
    Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    H. Frang et al., "Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors", J BIOL CHEM, 276(33), 2001, pp. 31279-31284
14. Govaerts, C; Blanpain, C; Deupi, X; Ballet, S; Ballesteros, JA; Wodak, SJ; Vassart, G; Pardo, L; Parmentier, M
    The TXP motif in the second transmembrane helix of CCR5 - A structural determinant of chemokine-induced activation
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    C. Govaerts et al., "The TXP motif in the second transmembrane helix of CCR5 - A structural determinant of chemokine-induced activation", J BIOL CHEM, 276(16), 2001, pp. 13217-13225
15. Jensen, AD; Guarnieri, F; Rasmussen, SGF; Asmar, F; Ballesteros, JA; Gether, U
    Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta(2) adrenergic receptor mapped by site-selectivefluorescent labeling
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A.D. Jensen et al., "Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta(2) adrenergic receptor mapped by site-selectivefluorescent labeling", J BIOL CHEM, 276(12), 2001, pp. 9279-9290
16. Shi, L; Simpson, MM; Ballesteros, JA; Javitch, JA
    The first transmembrane segment of the dopamine D2 receptor: Accessibilityin the binding-site crevice and position in the transmembrane bundle
    BIOCHEMISTRY
    
    L. Shi et al., "The first transmembrane segment of the dopamine D2 receptor: Accessibilityin the binding-site crevice and position in the transmembrane bundle", BIOCHEM, 40(41), 2001, pp. 12339-12348
17. Xu, W; Li, J; Chen, CG; Huang, P; Weinstein, H; Javitch, JA; Shi, L; de Riel, JK; Liu-Chen, LY
    Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors
    BIOCHEMISTRY
    
    W. Xu et al., "Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors", BIOCHEM, 40(27), 2001, pp. 8018-8029
18. Gupta, J; Evagelidis, A; Hanrahan, JW; Linsdell, P
    Asymmetric structure of the cystic fibrosis transmembrane conductance regulator chloride channel pore suggested by mutagenesis of the twelfth transmembrane region
    BIOCHEMISTRY
    
    J. Gupta et al., "Asymmetric structure of the cystic fibrosis transmembrane conductance regulator chloride channel pore suggested by mutagenesis of the twelfth transmembrane region", BIOCHEM, 40(22), 2001, pp. 6620-6627
19. Sealfon, SC
    Dopamine receptors and locomotor responses: Molecular aspects
    ANNALS OF NEUROLOGY
    
    S.C. Sealfon, "Dopamine receptors and locomotor responses: Molecular aspects", ANN NEUROL, 47(4), 2000, pp. S12-S21
20. Topham, CM; Mouledous, L; Meunier, JC
    On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family
    PROTEIN ENGINEERING
    
    C.M. Topham et al., "On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family", PROTEIN ENG, 13(7), 2000, pp. 477-490
21. Gether, U
    Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
    ENDOCRINE REVIEWS
    
    U. Gether, "Uncovering molecular mechanisms involved in activation of G protein-coupled receptors", ENDOCR REV, 21(1), 2000, pp. 90-113
22. Blaker, M; Ren, Y; Seshadri, L; McBride, EW; Beinborn, M; Kopin, AS
    CCK-B/gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides
    MOLECULAR PHARMACOLOGY
    
    M. Blaker et al., "CCK-B/gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides", MOLEC PHARM, 58(2), 2000, pp. 399-406
23. Allman, K; Page, KM; Curtis, CAM; Hulme, EC
    Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M-1 muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine
    MOLECULAR PHARMACOLOGY
    
    K. Allman et al., "Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M-1 muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine", MOLEC PHARM, 58(1), 2000, pp. 175-184
24. Fanelli, F
    Theoretical study on mutation-induced activation of the luteinizing hormone receptor
    JOURNAL OF MOLECULAR BIOLOGY
    
    F. Fanelli, "Theoretical study on mutation-induced activation of the luteinizing hormone receptor", J MOL BIOL, 296(5), 2000, pp. 1333-1351
25. Wilcox, RE; Huang, WH; Brusniak, MYK; Wilcox, DM; Pearlman, RS; Teeter, MM; DuRand, CJ; Wiens, BL; Neve, KA
    CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors
    JOURNAL OF MEDICINAL CHEMISTRY
    
    R.E. Wilcox et al., "CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors", J MED CHEM, 43(16), 2000, pp. 3005-3019
26. McCarty, NA
    Permeation through the CFTR chloride channel
    JOURNAL OF EXPERIMENTAL BIOLOGY
    
    N.A. McCarty, "Permeation through the CFTR chloride channel", J EXP BIOL, 203(13), 2000, pp. 1947-1962
27. Akabas, MH
    Cystic fibrosis transmembrane conductance regulator - Structure and function of an epithelial chloride channel
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M.H. Akabas, "Cystic fibrosis transmembrane conductance regulator - Structure and function of an epithelial chloride channel", J BIOL CHEM, 275(6), 2000, pp. 3729-3732
28. Liapakis, G; Ballesteros, JA; Papachristou, S; Chan, WC; Chen, X; Javitch, JA
    The forgotten serine - A critical role for Ser-203(5.42) in ligand bindingto and activation of the beta(2)-adrenergic receptor
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    G. Liapakis et al., "The forgotten serine - A critical role for Ser-203(5.42) in ligand bindingto and activation of the beta(2)-adrenergic receptor", J BIOL CHEM, 275(48), 2000, pp. 37779-37788
29. Koch, SE; Bodi, I; Schwartz, A; Varadi, G
    Architecture of Ca2+ channel pore-lining segments revealed by covalent modification of substituted cysteines
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.E. Koch et al., "Architecture of Ca2+ channel pore-lining segments revealed by covalent modification of substituted cysteines", J BIOL CHEM, 275(44), 2000, pp. 34493-34500
30. Dube, P; DeCostanzo, A; Konopka, JB
    Interaction between transmembrane domains five and six of the alpha-factorreceptor
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    P. Dube et al., "Interaction between transmembrane domains five and six of the alpha-factorreceptor", J BIOL CHEM, 275(34), 2000, pp. 26492-26499
31. Kaplan, RS; Mayor, JA; Brauer, D; Kotaria, R; Walters, DE; Dean, AM
    The yeast mitochondrial citrate transport protein - Probing the secondary structure of transmembrane domain IV and identification of residues that likely comprise a portion of the citrate translocation pathway
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    R.S. Kaplan et al., "The yeast mitochondrial citrate transport protein - Probing the secondary structure of transmembrane domain IV and identification of residues that likely comprise a portion of the citrate translocation pathway", J BIOL CHEM, 275(16), 2000, pp. 12009-12016
32. Oak, JN; Oldenhof, J; Van Tol, HHM
    The dopamine D-4 receptor: one decade of research
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    J.N. Oak et al., "The dopamine D-4 receptor: one decade of research", EUR J PHARM, 405(1-3), 2000, pp. 303-327
33. Ueno, S; Lin, A; Nikolaeva, N; Trudell, JR; Mihic, SJ; Harris, RA; Harrison, NL
    Tryptophan scanning mutagenesis in TM2 of the GABA(A) receptor alpha subunit: effects on channel gating and regulation by ethanol
    BRITISH JOURNAL OF PHARMACOLOGY
    
    S. Ueno et al., "Tryptophan scanning mutagenesis in TM2 of the GABA(A) receptor alpha subunit: effects on channel gating and regulation by ethanol", BR J PHARM, 131(2), 2000, pp. 296-302
34. Zhang, ZR; McDonough, SI; McCarty, NA
    Interaction between permeation and gating in a putative pore domain mutantin the cystic fibrosis transmembrane conductance regulator
    BIOPHYSICAL JOURNAL
    
    Z.R. Zhang et al., "Interaction between permeation and gating in a putative pore domain mutantin the cystic fibrosis transmembrane conductance regulator", BIOPHYS J, 79(1), 2000, pp. 298-313
35. Linsdell, P; Evagelidis, A; Hanrahan, JW
    Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore
    BIOPHYSICAL JOURNAL
    
    P. Linsdell et al., "Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore", BIOPHYS J, 78(6), 2000, pp. 2973-2982
36. Norregaard, L; Visiers, I; Loland, CJ; Ballesteros, J; Weinstein, H; Gether, U
    Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites
    BIOCHEMISTRY
    
    L. Norregaard et al., "Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites", BIOCHEM, 39(51), 2000, pp. 15836-15846
37. Xu, W; Chen, CG; Huang, P; Li, J; de Riel, JK; Javitch, JA; Liu-Chen, LY
    The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors
    BIOCHEMISTRY
    
    W. Xu et al., "The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors", BIOCHEM, 39(45), 2000, pp. 13904-13915
38. Javitch, JA; Shi, L; Simpson, MM; Chen, JY; Chiappa, V; Visiers, I; Weinstein, H; Ballesteros, JA
    The fourth transmembrane segment of the dopamine D2 receptor: Accessibility in the binding-site crevice and position in the transmembrane bundle
    BIOCHEMISTRY
    
    J.A. Javitch et al., "The fourth transmembrane segment of the dopamine D2 receptor: Accessibility in the binding-site crevice and position in the transmembrane bundle", BIOCHEM, 39(40), 2000, pp. 12190-12199
39. Hallen, S; Fryklund, J; Sachs, G
    Inhibition of the human sodium/bile acid cotransporters by side-specific methanethiosulfonate sulfhydryl reagents: Substrate-controlled accessibilityof site of inactivation
    BIOCHEMISTRY
    
    S. Hallen et al., "Inhibition of the human sodium/bile acid cotransporters by side-specific methanethiosulfonate sulfhydryl reagents: Substrate-controlled accessibilityof site of inactivation", BIOCHEM, 39(22), 2000, pp. 6743-6750
40. Reggio, PH
    Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: Achievements and challenges
    CURRENT MEDICINAL CHEMISTRY
    
    P.H. Reggio, "Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: Achievements and challenges", CURR MED CH, 6(8), 1999, pp. 665-683
41. Lomize, AL; Pogozheva, ID; Mosberg, HI
    Structural organization of G-protein-coupled receptors
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    
    A.L. Lomize et al., "Structural organization of G-protein-coupled receptors", J COMPUT A, 13(4), 1999, pp. 325-353
42. Boileau, AJ; Evers, AR; Davis, AF; Czajkowski, C
    Mapping the agonist binding site of the GABA(A) receptor: Evidence for a beta-strand
    JOURNAL OF NEUROSCIENCE
    
    A.J. Boileau et al., "Mapping the agonist binding site of the GABA(A) receptor: Evidence for a beta-strand", J NEUROSC, 19(12), 1999, pp. 4847-4854
43. Filizola, M; Laakkonen, L; Loew, GH
    3D modeling, ligand binding and activation studies of the cloned mouse delta, mu and kappa opioid receptors
    PROTEIN ENGINEERING
    
    M. Filizola et al., "3D modeling, ligand binding and activation studies of the cloned mouse delta, mu and kappa opioid receptors", PROTEIN ENG, 12(11), 1999, pp. 927-942
44. Song, ZH; Slowey, CA; Hurst, DP; Reggio, PH
    The difference between the CB1 and CB2 cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB2
    MOLECULAR PHARMACOLOGY
    
    Z.H. Song et al., "The difference between the CB1 and CB2 cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB2", MOLEC PHARM, 56(4), 1999, pp. 834-840
45. Rasmussen, SGF; Jensen, AD; Liapakis, G; Ghanouni, P; Javitch, JA; Gether, U
    Mutation of a highly conserved aspartic acid in the beta(2) adrenergic receptor: Constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6
    MOLECULAR PHARMACOLOGY
    
    S.G.F. Rasmussen et al., "Mutation of a highly conserved aspartic acid in the beta(2) adrenergic receptor: Constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6", MOLEC PHARM, 56(1), 1999, pp. 175-184
46. Chan, BS; Satriano, JA; Schuster, VL
    Mapping the substrate binding site of the prostaglandin transporter PGT bycysteine scanning mutagenesis
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    B.S. Chan et al., "Mapping the substrate binding site of the prostaglandin transporter PGT bycysteine scanning mutagenesis", J BIOL CHEM, 274(36), 1999, pp. 25564-25570
47. Marjamaki, A; Frang, H; Pihlavisto, M; Hoffren, AM; Salminen, T; Johnson, MS; Kallio, J; Javitch, JA; Scheinin, M
    Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A. Marjamaki et al., "Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human alpha(2A)-adrenergic receptor", J BIOL CHEM, 274(31), 1999, pp. 21867-21872
48. Chen, SH; Xu, M; Lin, F; Lee, D; Riek, P; Graham, RM
    Phe(310) in transmembrane VI of the alpha(1B)-adrenergic receptor is a keyswitch residue involved in activation and catecholamine ring aromatic bonding
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.H. Chen et al., "Phe(310) in transmembrane VI of the alpha(1B)-adrenergic receptor is a keyswitch residue involved in activation and catecholamine ring aromatic bonding", J BIOL CHEM, 274(23), 1999, pp. 16320-16330
49. Baranski, TJ; Herzmark, P; Lichtarge, O; Gerber, BO; Trueheart, J; Meng, EC; Iiri, T; Sheikh, SP; Bourne, HR
    C5a receptor activation - Genetic identification of critical residues in four transmembrane helices
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    T.J. Baranski et al., "C5a receptor activation - Genetic identification of critical residues in four transmembrane helices", J BIOL CHEM, 274(22), 1999, pp. 15757-15765
50. Guinamard, R; Akabas, MH
    Arg352 is a major determinant of charge selectivity in the cystic fibrosistransmembrane conductance regulator chloride channel
    BIOCHEMISTRY
    
    R. Guinamard e M.H. Akabas, "Arg352 is a major determinant of charge selectivity in the cystic fibrosistransmembrane conductance regulator chloride channel", BIOCHEM, 38(17), 1999, pp. 5528-5537
51. WESS J
    MOLECULAR-BASIS OF RECEPTOR G-PROTEIN-COUPLING SELECTIVITY/
    Pharmacology & therapeutics (Oxford)
    
    J. Wess, "MOLECULAR-BASIS OF RECEPTOR G-PROTEIN-COUPLING SELECTIVITY/", Pharmacology & therapeutics (Oxford), 80(3), 1998, pp. 231-264
52. KONVICKA K; GUARNIERI F; BALLESTEROS JA; WEINSTEIN H
    A PROPOSED STRUCTURE FOR TRANSMEMBRANE SEGMENT-7 OF G-PROTEIN-COUPLEDRECEPTORS INCORPORATING AN ASN-PRO ASP-PRO MOTIF/
    Biophysical journal
    
    K. Konvicka et al., "A PROPOSED STRUCTURE FOR TRANSMEMBRANE SEGMENT-7 OF G-PROTEIN-COUPLEDRECEPTORS INCORPORATING AN ASN-PRO ASP-PRO MOTIF/", Biophysical journal, 75(2), 1998, pp. 601-611
53. POGOZHEVA ID; LOMIZE AL; MOSBERG HI
    OPIOID RECEPTOR 3-DIMENSIONAL STRUCTURES FROM DISTANCE GEOMETRY CALCULATIONS WITH HYDROGEN-BONDING CONSTRAINTS
    Biophysical journal
    
    I.D. Pogozheva et al., "OPIOID RECEPTOR 3-DIMENSIONAL STRUCTURES FROM DISTANCE GEOMETRY CALCULATIONS WITH HYDROGEN-BONDING CONSTRAINTS", Biophysical journal, 75(2), 1998, pp. 612-634
54. BALDWIN JM; SCHERTLER GFX; UNGER VM
    AN ALPHA-CARBON TEMPLATE FOR THE TRANSMEMBRANE HELICES IN THE RHODOPSIN FAMILY OF G-PROTEIN-COUPLED RECEPTORS
    Journal of Molecular Biology
    
    J.M. Baldwin et al., "AN ALPHA-CARBON TEMPLATE FOR THE TRANSMEMBRANE HELICES IN THE RHODOPSIN FAMILY OF G-PROTEIN-COUPLED RECEPTORS", Journal of Molecular Biology, 272(1), 1997, pp. 144-164
55. GOULDSON PR; SNELL CR; REYNOLDS CA
    A NEW APPROACH TO DOCKING IN THE BETA(2)-ADRENERGIC RECEPTOR THAT EXPLOITS THE DOMAIN-STRUCTURE OF G-PROTEIN-COUPLED RECEPTORS
    Journal of medicinal chemistry
    
    P.R. Gouldson et al., "A NEW APPROACH TO DOCKING IN THE BETA(2)-ADRENERGIC RECEPTOR THAT EXPLOITS THE DOMAIN-STRUCTURE OF G-PROTEIN-COUPLED RECEPTORS", Journal of medicinal chemistry, 40(24), 1997, pp. 3871-3886